A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Open accessThe DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index; 20 of the 36 sources its claims cite were checked for support.
Abstract
Oncogene-induced senescence (OIS) is crucial for tumour suppression. Senescent cells implement a complex pro-inflammatory response termed the senescence-associated secretory phenotype (SASP). The SASP reinforces senescence, activates immune surveillance and paradoxically also has pro-tumorigenic properties. Here, we present evidence that the SASP can also induce paracrine senescence in normal cells both in culture and in human and mouse models of OIS in vivo. Coupling quantitative proteomics with small-molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF-β family ligands, VEGF, CCL2 and CCL20. Amongst them, TGF-β ligands play a major role by regulating p15(INK4b) and p21(CIP1). Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling. The inflammasome and IL-1 signalling are activated in senescent cells and IL-1α expression can reproduce SASP activation, resulting in senescence. Our results demonstrate that the SASP can cause paracrine senescence and impact on tumour suppression and senescence in vivo.
Overview
CoChat Summary
## TL;DR
Cells undergoing oncogene-induced senescence (OIS) can transmit senescence to neighboring normal cells through secreted SASP factors, creating a stable paracrine senescence state in culture and in vivo. The paper identifies TGFβ family ligands and IL-1/inflammasome signaling as key regulators of this process.
## Key findings
- Normal IMR90 fibroblasts and HMECs became growth-arrested when co-cultured with OIS cells; the effect was transmitted through transwells and conditioned media, showing it was mediated by soluble factors rather than direct contact.
- Paracrine senescence resembled full senescence: normal cells showed increased DNA/oxidative damage, p16^INK4a^, p21^CIP1^, and SASP markers; gene-expression profiles of OIS and paracrine senescence were highly correlated and clustered together.
- Quantitative proteomics and a 78-compound screen implicated multiple SASP components in paracrine senescence, including TGFβ family ligands, VEGF, CCL2, and CCL20; blocking VEGFR2/FLT3, TGFBR1, or CCR2 partially impaired the arrest.
- The paper reports specific in vivo evidence of paracrine senescence: p21^CIP1^+/p16^INK4a^ cells were found near OIS lesions in mouse liver and skin, and in human serrated sessile adenomas the stromal p21^CIP1^/Ki-67^- signal was significantly increased near lesions (p = 0.03), with a separate comparison reporting p = 4.6 × 10^-5^ for p21^CIP1^ positive/Ki67 negative stromal cells.
## Methods
- Co-culture, transwell, conditioned-media, and cluster assays were used in human IMR90 fibroblasts and HMECs; OIS was induced with ER:RAS, MEK:ER, or related oncogenic constructs activated by 4OHT.
- Secretome analysis used SILAC-based quantitative proteomics, followed by a 78-compound receptor/pathway screen, RNAi knockdown, RT-qPCR, microarrays, GSEA, immunofluorescence/high-content analysis, and assays for BrdU, SA-β-Gal, caspase-1, and antibody arrays.
- In vivo validation used mouse OIS models including Nras-driven hepatocyte senescence, K5-Sos/Egfr^wa2/+^ skin papillomas, and Pdx1-Cre Kras^G12D^ pancreatic lesions, plus human SSA tissue IHC.
## Limitations
- The paper itself notes that “the nature of these cells and the functional implications of paracrine senescence remain open questions for future studies.”
- It also states that not all cells surrounding preneoplastic lesions undergo paracrine senescence; it proposes possible explanations such as soluble-factor gradients and cell-type susceptibility, but these are not experimentally resolved here.
- Evident from the text: many mechanistic and inhibitor results are partial (“partially rescued,” “partially prevented”), so the study does not identify a single exclusive mediator of paracrine senescence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Valid · 1 Not valid · 7 Not checked · 78 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“a transcriptional signature associated with senescence 18 was significantly upregulated during paracrine senescence (Fig 3d).”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence resembles a full senescence response
What the sources say
- Supportedcites [18] Fridman AL, Tainsky MA. Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene. 2008; 27:5975-87. [PubMed: 18711403] source
The 'Genomic approaches to identify senescence/immortalization genes and pathways' section describes gene-expression profiling that identifies genes and pathways associated with senescence. In the citing sentence, the citation identifies the senescence-associated transcriptional signature; the finding that it was significantly upregulated during paracrine senescence is attributed to the citing paper’s Fig. 3d, not to this source. No page number is available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Colon SSAs are mainly driven by activating BRAF mutations that trigger OIS 31,34,35 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence is observed in mouse and human models of OIS in vivo
What the sources say
- Partly supportedcites [31] Carragher LA, et al. V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a. EMBO Mol Med. 2010; 2:458-71. [PubMed: 20941790] sourceExperimental — accuracy not yet measured
The Discussion reports V600E BRAF mutations in approximately 70% of right-sided serrated hyperplastic polyps and serrated adenomas, supporting a major role for BRAF in the serrated pathway. The Results show that V600E Braf induces senescence in mouse small-intestinal crypts, but do not establish that BRAF mutations trigger OIS in human colon sessile serrated adenomas. (LLM, conf=0.87)
- Partly supportedcites [34] Kriegl L, et al. Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/ adenomas indicates a senescence barrier in the serrated route to colon cancer. Modern Pathology. 2011; 24:1015-22. [PubMed: 21423154] sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says that initiating BRAF mutations might drive oncogene-induced senescence in human serrated polyps, and concludes that the data provide evidence for senescence in the BRAF-mutated serrated route. It does not establish that colon sessile serrated adenomas are mainly driven by BRAF mutations: the study selected BRAF-mutated lesions for its final analysis, and its proposed causal link is hedged. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [35] Bennecke M, et al. Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis. Cancer Cell. 2010; 18:135-46. [PubMed: 20708155] source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A signature derived from IMR90 cells undergoing paracrine senescence is found enriched in mouse PANIN 44 and human serrated sessile adenomas (SSA) 36 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > REFERENCES
What the sources say
- Partly supportedcites [44] Ling J, et al. KrasG12D-induced IKK2/beta/NF-kappaB activation by IL-1alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell. 2012; 21:105-20. [PubMed: 22264792] sourceExperimental — accuracy not yet measured
The Results section, “Inhibition of Key Proinflammatory Cytokines,” reports gene-expression profiles from mouse PanIN, so this paper provides the mouse PanIN data cited as reference 44. It does not report testing or finding enrichment of an IMR90 paracrine-senescence signature in those profiles. The SSA finding is attached to a different citation (36), not this source. (LLM, conf=0.79)
- Not checked — no full text of the sourcecites [36] Caruso M, et al. Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. Virchows Archiv. 2009; 454:291-302. [PubMed: 19172291] source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
- Also stated in: § Abstract · plain
“Coupling quantitative proteomics with small molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling.”
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
54 more claims
Create a free account to see all 101 claims and every source verdict.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 21
- The quote only partly states this claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The senescent cell fate can be triggered by a number of stressors including DNA damage, cancerous mutations or oncogene activation, mitochondrial dysfunction, reactive metabolites, hyperoxia or hypoxia, proteotoxic stress, extracellular signals, infections, mechanical or shear stresses that deform cells, resistance exercise and factors secreted by other senescent cells18,38–47.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The inflammasome, a multiprotein complex comprising caspase 1 and key regulators of the defence mechanisms against pathogens117, and Toll-like receptors, which regulate the inflammasome, have been reported to promote maturation and secretion of SASP factors during OIS73,118.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, specific SASP components, either soluble or in extracellular vesicles186, can induce senescence in a paracrine manner — which includes DDR activation73,83.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upstream signals triggering SASP activation are multiple and differ depending on the senescence inducer but include DNA damage, cytoplasmic chromatin fragments (CCFs) that trigger a type 1 interferon response, and damage-associated molecular patterns (DAMPs) that activate the inflammasome (Acosta et al., 2013; Davalos et al., 2013; Li and Chen, 2018).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Higher secretion of SASP factors is also associated with an enhanced immune response, leading to inflammation which may promote tumorigenesis (Acosta et al., 2013).”
From Single senescent cell sequencing reveals heterogeneity in senescent cells induced by telomere erosion (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measured
47 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Self-citationPreinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Cited by
Items 1,401–1,500 of 2,275
Small, S. H., Tang, E. J., Ragland, R. L., Ruzankina, Y., Schoppy, D. W., Mandal, R. S., Glineburg, M. R., Ustelenca, Z., Powell, D. J., Simpkins, F. A., et al. (2021) · Science Signaling · doi:10.1126/scisignal.aba2611 · Cited by 14
“To examine the effect of inhibiting inflammasome-mediated processing on IL19 expression, cells were treated with a selective inhibitor of caspase-1, an inflammasome component that is required for efficient IL-1 processing and production (10, 11), immediately after IR treatment.”
BackgroundHe, Y., Lipa, K. E., Alexander, P. G., Clark, K. L., & Lin, H. (2022) · Biology · doi:10.3390/biology11070996 · Cited by 16
Hodge, J., Robinson, J. L., & Mellott, A. J. (2022) · Regenerative Medicine · doi:10.2217/rme-2022-0140 · Cited by 11
A Senomorphic‐Conjugated Scaffold for Application of Senescent Cells in Regenerative Medicine
Deng, W., Jun-ichiro, J. O., Tanaka, T., Morikuni, H., Hashimoto, Y., Matsumoto, N., & Honda, Y. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202200276 · Cited by 14
Cellular senescence and developmental defects
Klein, A., Rhinn, M., & Keyes, W. M. (2023) · FEBS Journal · doi:10.1111/febs.16731 · Cited by 14
Palbociclib-Induced Cellular Senescence Is Modulated by the mTOR Complex 1 and Autophagy
Cayo, Á., Venturini, W., Rebolledo-Mira, D., Moore‐Carrasco, R., Herrada, A. A., Nova‐Lamperti, E., Valenzuela, C. A., & Brown, N. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119284 · Cited by 14
“While some of these factors can maintain, or even promote, senescence in a paracrine manner [21], other SASP factors with documented proinflammatory action [22] can promote a pro-tumorigenic microenvironment that can lead to tumor recurrence or acceleration of tumor progression [23–25].”
BackgroundJinushi, M. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9501-9 · Cited by 11
“However, the inflammatory mediators secreted by SASP also act as tumor suppressors and augment therapeutic responses to chemotherapy by activating innate effector cells such as NK cells and macrophages [46, 51–53].”
BackgroundThe ING1a model of rapid cell senescence
Bertschmann, J., Thalappilly, S., & Riabowol, K. T. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.06.004 · Cited by 14
Senescence and senotherapies in biliary atresia and biliary cirrhosis
Jannone, G., Bonaccorsi‐Riani, E., de Magnée, C., Tambucci, R., Evraerts, J., Ravau, J., Baldin, P., Bouzin, C., Loriot, A. E., Gatto, L., et al. (2023) · Aging · doi:10.18632/aging.204700 · Cited by 17
The potential of targeting Sin3B and its associated complexes for cancer therapy
Cantor, D. J., & David, G. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1386655 · Cited by 11
“crine manner to reinforce cellular senescence and promote senescence in neighboring cells [75,77,78].”
BackgroundRole of Senescence and Neuroprotective Effects of Telomerase in Neurodegenerative Diseases
Ding, X., Liu, X., Wang, F., Wang, F., & Geng, X. (2019) · Rejuvenation Research · doi:10.1089/rej.2018.2115 · Cited by 12
“51,63 They are capable of generating high concentrations of proinflammatory factors, such as cytokines, chemokines, growth factors, and proteases, that contribute to local inflammation which is implicated in the development of chronic diseases such as neurodegenerative diseases.”
Metabolic dysregulation of trained immunity in immune aging and the impact of dietary patterns
Grigorescu, A., Riza, A., Streață, I., & Netea, M. G. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00153.2025 · Cited by 17
Lewis, L., Valvi, D., Gedaly, R., & Martí, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1621759 · Cited by 13
“…factors, and proteases that can induce secondary senescence in surrounding healthy cells and tissues – a phenomenon known as the senescence-associated secretory phenotype (SASP) (111, 112), which can contribute to amplify the chronic in fl ammation that drives aging and its associated pathologies.”
The Role of Renal Cell Senescence in Diabetic Kidney Disease: Mechanisms and Therapeutic Advances
Yan, Z., Xu, J., Liu, T., Wang, L., Zhang, Q., Li, X., Lin, B., & Piao, C. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s543814 · Cited by 14
Mitigating Pro‐Inflammatory SASP and DAMP With Urolithin A: A Novel Senomorphic Strategy
Barkovskaya, A., Brauning, A., Thambala, A., Bhardwaj, K., Chamoli, M., Rane, A., Andersen, J. K., & Sharma, A. (2025) · Aging Cell · doi:10.1111/acel.70237 · Cited by 12
Translating cellular senescence research into clinical practice for metabolic disease
Chaib, S., Palmer, A. K., Wyles, S. P., Musi, N., Kirkland, J. L., & Tchkonia, T. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01187-9 · Cited by 18
“Regarding the detrimental role of senescent cells, the SASP can exacerbate tissue dysfunction through paracrine and endocrine mechanisms and can itself induce senescence locally or in distant tissues 16,17 .”
Hypertension-induced neurovascular and cognitive dysfunction at single-cell resolution
Schaeffer, S. M., Pacholko, A. G., Santisteban, M. M., Ahn, S. J., Racchumi, G., Wang, G., Park, L., Faraco, G., Anrather, J., & Iadecola, C. (2025) · Neuron · doi:10.1016/j.neuron.2025.10.018 · Cited by 17
Sex-Specific Diet–Microbiota Interactions in Ageing: Implications for Healthy Longevity
Hernández-Acosta, J., Tovar, A. R., & Torres, N. (2025) · Nutrients · doi:10.3390/nu17243833 · Cited by 11
“…by the release of inflammatory mediators (IL-6 and C-C motif chemokine ligand 1 (CCL-1)), chemokines (CXCL-8), matrix metalloproteinases (MMP-1, MMP-3), reactive oxygen species (ROS), and Damage-Associated Molecular Patterns (DAMPS), all of which reinforce the chronic inflammatory milieu [72,73].”
Non-Intrinsic, Systemic Mechanisms of Cellular Senescence
Schwartz, R. E., & Conboy, I. M. (2023) · Cells · doi:10.3390/cells12242769 · Cited by 11
“Paracrine senescence can also be mediated by TGF-β family ligands [30,31], VEGF, CCL2, CCL20 [31] CXCL10/IP-10 [32], and insulin-like growth factor binding protein 3 [33].”
BackgroundConde-Torres, D., Blanco-González, A., Seco-González, A., Suárez-Lestón, F., Cabezón, A., Antelo-Riveiro, P., Piñeiro, Á., & García‐Fandiño, R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1320779 · Cited by 13
Mapping the core senescence phenotype of primary human colon fibroblasts
Hattangady, N. G., Carter, K. T., Maroni-Rana, B., Wang, T., Ayers, J., Yu, M., & Grady, W. M. (2024) · Aging · doi:10.18632/aging.205577 · Cited by 15
Fibroblast senescence-associated extracellular matrix promotes heterogeneous lung niche
Howes, A. M., Dea, N. C., Ghosh, D., Krishna, K., Wang, Y., Li, Y., Morrison, B., Toussaint, K. C., & Dawson, M. (2024) · APL Bioengineering · doi:10.1063/5.0204393 · Cited by 17
Cellular senescence mediates retinal ganglion cell survival regulation post‐optic nerve crush injury
Yao, Y., Bin, X., Xu, Y., Chen, S., Chen, S., Yuan, X., Cao, Y., & Ng, T. K. (2024) · Cell Proliferation · doi:10.1111/cpr.13719 · Cited by 10
“All statistical analyses were conducted by IBM SPSS Statistics 23 (SPSS Inc., Chicago, IL).”
Systematic transcriptomic analysis and temporal modelling of human fibroblast senescence
Scanlan, R.-L., Pease, L., O’Keefe, H., Guimera, A. M., Rasmussen, L. J., Wordsworth, J., & Shanley, D. P. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1448543 · Cited by 11
ANGPTL4-the Link Binding Lipid Metabolism and Inflammation
Zhang, Y., Liang, J., Li, Z., Zuo, Y., & Dai, L. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673320024240829070906 · Cited by 12
Abdelmoaty, A. A. A., Chen, J., Zhang, K., Wu, C., Li, Y., Li, P., & Xu, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1422363 · Cited by 11
The putative contribution of cellular senescence to driving tauopathies
Karabag, D., Heneka, M. T., & Ising, C. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.08.006 · Cited by 11
Targeting treatment resistance in cervical cancer: A new avenue for senolytic therapies
Meyer, M., Fourie, C., der Merwe, F. H. V., Botha, M. H., & Engelbrecht, A. (2024) · Advances in Medical Sciences · doi:10.1016/j.advms.2024.11.001 · Cited by 11
Intracellular HIV-1 Tat regulator induces epigenetic changes in the DNA methylation landscape
Rodríguez-Agustín, A., Ayala-Suárez, R., Díez‐Fuertes, F., Maleno, M. J., Villasante, I., Merkel, A., Coiras, M., Casanova, V., Alcamí, J., & Climent, N. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1532692 · Cited by 15
Chemically Induced Senescence Prompts Functional Changes in Human Microglia‐Like Cells
Armanville, S., Tocco, C., Mohamad, Z., Clarke, D., Robitaille, R., & Drouin‐Ouellet, J. (2025) · Journal of Immunology Research · doi:10.1155/jimr/3214633 · Cited by 11
Peng, L., Qiao, L., Xue, Z., Yang, Y., Zheng, G., Tan, L., Zhang, C., Liu, X., & Wu, Z. (2025) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2025.137804 · Cited by 11
Gu, C., Guo, T., Chen, X., Zhou, X., & Sun, Y. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01580-y · Cited by 11
“…can exacerbate the inflammatory environment and following neuronal damage by the release of senescence-associated secretory phenotype (SASP), including proinflammatory cytokines, chemokines, proteases, growth factors and secreted proteins (Ohtani 2022; Acosta et al. 2013; Kuilman et al. 2008).”
InfluentialCharacterizing primary and secondary senescence in vivo
Sogabe, Y., Shibata, H., Kabata, M., Tanaka, A., Mitsunaga, K., Sunadome, K., Nakajima‐Koyama, M., Hirano, M., Nishida, E., Woltjen, K., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00917-y · Cited by 16
“Recent studies have uncovered that SASP factors, IL-1, transforming growth factor-β and Notch, can induce secondary senescence through paracrine or juxtracrine mechanisms 11,22,24,44 .”
InfluentialBCG vaccination and the risk of COVID 19: A possible correlation
Ahmed, S. M., Nasr, M. A., Elshenawy, S. E., Hussein, A. E., El-Betar, A. H., Mohamed, R. H., & El‐Badri, N. (2021) · Virology · doi:10.1016/j.virol.2021.10.003 · Cited by 12
Extracellular Vesicles: Footprints of environmental exposures in the aging process?
Monti, P., Solazzo, G., Ferrari, L., & Bollati, V. (2021) · Current Environmental Health Reports · doi:10.1007/s40572-021-00327-3 · Cited by 10
“Another study reported that repetitive exposure to physiological UV doses stimulates the premature acquisition of a senescent phenotype by melanocytes, together with the shedding of EXO-borne miRNAs which regulate genes encoding for SASP proteins and other senescence-associated factors [89].”
BackgroundInfluentialMa, X., Gao, Y., Liu, J., Xu, L., Liu, W., Huna, A., Wang, X., & Gong, W. (2022) · IUBMB Life · doi:10.1002/iub.2651 · Cited by 10
“The SASP components, chemokine receptor CXCR2 as an example, were demonstrated to reinforce senescence through an autocrine pathway,(20) whereas a paracrine effect of SASP factors, such as inflammasome and IL1 signaling, to induce senescence of neighboring cells was later reported.(21) Here we showed senescent breast…”
BackgroundZhuang, Z., Zhong, X., Chen, Q., Chen, H., & Liu, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.857730 · Cited by 13
“…increasing IFN secretion in infected cells, and danger-associated molecular patterns released in cells undergoing pyroptosis or necroptosis further accelerated senescence in the environment via SASP factors (Kim et al., 2009; Acosta et al., 2013; Kandhaya-Pillai et al., 2017; Nehme et al., 2020).”
BackgroundLi, J., Wang, J., Liu, D., Tao, C., Zhao, J., & Wang, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1018942 · Cited by 9
“SASP-related immune response eliminated the further expansion of deleterious cells and suppressed the tumorigenesis, imposing an antitumor effect (36, 37).”
BackgroundDysfunction of programmed embryo senescence is linked to genetic developmental defects
Lope, C. D., García-Lucena, R., Magariños, M., León, Y., Casa-Rodríguez, N., Contreras, N., Escudero‐Iriarte, C., Varela‐Nieto, I., Maire, P., & Palmero, I. (2023) · Development · doi:10.1242/dev.200903 · Cited by 14
Pizzuti, V., Paris, F., Marrazzo, P., Bonsi, L., & Alviano, F. (2023) · Biomolecules · doi:10.3390/biom13060971 · Cited by 11
“In addition to replicative senescence, which is characterized by a progressive reduction in telomere length in cells undergoing mitotic cell divisions and was first described by Hayflick and Moorehead [10], there are also a variety of senescence types that are related to extrinsic and/or intrinsic stress, for example,…”
BackgroundSaleh, T., Naffa, R. G., Barakat, N. A., Ismail, M. A., Alotaibi, M. R., & Alsalem, M. (2024) · Neurotoxicity Research · doi:10.1007/s12640-024-00690-7 · Cited by 11
“More importantly, senescent cells exhibit vast alterations in gene and protein expression leading to the secretion of a plethora of soluble and insoluble proteins termed the Senescence-associated Secretory Phenotype (SASP) (Coppé et al. 2010; Acosta et al. 2013; Basisty et al. 2020).”
Chen, P., Wang, Y., & Zhou, B. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111918 · Cited by 13
Non‐pituitary growth hormone enables colon cell senescence evasion
Chesnokova, V., Zonis, S., Apaydın, T., Barrett, R. J., & Melmed, S. K. (2024) · Aging Cell · doi:10.1111/acel.14193 · Cited by 10
“SASP at-tracts immune effectors, leading to senescent cell depletion (Kang et al., 2011; Lee & Schmitt, 2019 ; Xue et al., 2007), and secondary senescence induction in neighboring cells (Acosta et al., 2013; Kuilman & Peeper, 2009 ).”
Tissue engineering to better understand senescence: Organotypics come of age
Milligan, D., Tyler, E. J., & Bishop, C. L. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111261 · Cited by 11
Why Do the Cosmic Rays Induce Aging?
Giovanetti, A., Tortolici, F., & Rufini, S. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00955 · Cited by 12
“This phenomenon, generically called bystander effect, passes through the release by the secretory senescent cells [senescence-associated secretory phenotype (SASP)] of a complex secretome, which includes cytokines, growth factors, and microvesicles (Acosta et al., 2013; Urbanelli et al., 2016).”
BackgroundBryson, B. L., Tamagno, I., Taylor, S. E., Parameswaran, N., Chernosky, N. M., Balasubramaniam, N., & Jackson, M. W. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-1181 · Cited by 14
“Inflammatory cytokines are major regulators of senescence (4, 25).”
BackgroundInflammaging in skin and intrinsic underlying factors
Aioi, A. (2021) · Trends in Immunotherapy · doi:10.24294/ti.v5.i2.1342 · Cited by 9
“The presence of SASP factors such as MMP3, MMP9, IL-6, IL-8, and insulin-like growth factor binding protein 7 has been used as a marker for senescent dermal fibroblasts and melanocytes[58-60].”
BackgroundInfluentialInvolvement of astrocyte senescence in Alzheimer's disease
Tüzer, F., & Torres, C. A. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102594 · Cited by 12
Angiopoietin-like 2 is essential to aortic valve development in mice
Labbé, P., Goyette, V. M., Thorin‐Trescases, N., Villeneuve, L. R., Desanlis, I., Delwarde, C., Shi, Y., Martel, C., Yu, C., Alikashani, A., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-04243-6 · Cited by 11
The benefits of aging: cellular senescence in normal development
Pérez-Garijo, A., & Steller, H. (2013) · The EMBO Journal · doi:10.1002/embj.201387401 · Cited by 12
Melatonin in Healthy Aging and Longevity
Hardeland, R. (2017) · Healthy ageing and longevity · doi:10.1007/978-3-319-63001-4_10 · Cited by 13
Iop, L., Sasso, E. D., Schirone, L., Forte, M., Peruzzi, M., Cavarretta, E., Palmerio, S., Gerosa, G., Sciarretta, S., & Frati, G. (2017) · Mediators of Inflammation · doi:10.1155/2017/7953486 · Cited by 10
“Endowed with this senescence-associated secretory phenotype (SASP), cells exert a paracrine effect on neighboring cells, as well as an autocrine conditioning [11].”
BackgroundUnSASPing Senescence: Unmasking Tumor Suppression?
Schmitt, C. A. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.06.009 · Cited by 11
Senescent cells in the development of cardiometabolic disease
Postmus, A. C., Sturmlechner, I., Jonker, J. W., van Deursen, J. M., van de Sluis, B., & Kruit, J. K. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000602 · Cited by 10
Gaikwad, S., Puangmalai, N., Bittar, A., Montalbano, M., Garcia, S., McAllen, S., Bhatt, N., Sengupta, U., & Kayed, R. (2020) · Social Science Research Network · doi:10.2139/ssrn.3753798 · Cited by 5
The impacts of chronic infections on shaping cellular senescence
Johnson, A., Rought, T., Aronov, J., Pokharel, P., Chiu, A., & Nasuhidehnavi, A. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00533-9 · Cited by 14
“A defining feature of senescent cells is the senescence-associated secretory phenotype (SASP), which is characterized by the secretion of inflammatory cytokines and chemokines, growth factors and proteases [18, 19].”
Suk, K. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115737 · Cited by 13
Cau, P., Navarro, C. L., Harhouri, K., Roll, P., Sigaudy, S., Kaspi, É., Perrin, S., Sandre‐Giovannoli, A. D., & Lévy, N. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.03.022 · Cited by 11
Nanomedicines targeting the inflammasome as a promising therapeutic approach for cell senescence
Chaturvedi, S., Naseem, Z., El‐Khamisy, S. F., & Wahajuddin, M. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.08.008 · Cited by 10
Senescence in Osteoarthritis: Overview of Mechanisms and Therapeutics
Surmachevska, N., & Rubio, J. (2023) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2023.22077 · Cited by 15
“11 The SASPs include cytokines [interleukin (IL)-1b, IL-6, and tumor necrosis factor (TNF)-alpha], matrix degradation enzymes (metalloproteinases), and chemokines such as CCL2 and MCP1.”
BackgroundA narrative review on inflammaging and late-onset hypogonadism
Xing, D., Jin, Y., & Jin, B. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1291389 · Cited by 16
Huang, X.-C., Jiang, Y.-N., Bao, H., Wang, J., Lin, R., Yuan, J., Xian, J., Zhao, Y., & Chen, S. (2024) · Aging and Disease · doi:10.14336/ad.2024.0126 · Cited by 23
Sizek, H., Deritei, D., Fleig, K., Harris, M., Regan, P., Glass, K., & Regan, E. R. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102084 · Cited by 11
“Due to their enhanced ROS production, MiDAS cells may also be responsible for the population-dependent increase in senescent cell accumulation [122], shown to explain organism-level features of aging [123].”
Impact of Senescent Cell‐Derived Extracellular Vesicles on Innate Immune Cell Function
Chen, Y., Sullivan, J., Hanley, S., Price, J. M. J., Tariq, M. A., McIlvenna, L. C., Whitham, M., Sharma‐Oates, A., Harrison, P., Lord, J. M., et al. (2024) · Advanced Biology · doi:10.1002/adbi.202400265 · Cited by 11
Kim, D., Jeong, D. S., Park, S. Y., Jung, J., Lee, J. E., Lee, J., Baek, S., Lee, D. R., & Han, D. K. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202403944 · Cited by 10
HIV-Tat upregulates the expression of senescence biomarkers in CD4+ T-cells
Casanova, V., Rodríguez-Agustín, A., Ayala-Suárez, R., Moraga, E., Maleno, M. J., Mallolas, J., Martínez, E., Sánchez‐Palomino, S., Miró, J. M., Alcamí, J., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1568762 · Cited by 10
Pulmonary fibrosis and exosomes: pathways to treatment
Nija, R. J., & Nithya, T. G. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10855-y · Cited by 12
Immunosenescence and organoids: pathophysiology and therapeutic opportunities
Kamroo, A., Kakroudi, M. H., Sarmadian, A. J., Firouzabadi, A., Mousavi, S., Yazdanpanah, N., Saleki, K., & Rezaei, N. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00530-y · Cited by 13
“Importantly, the IL-1 and inflammasomes govern the initiation of paracrine senescence [230].”
Mehta, I. S., Riyahi, K., Pereira, R. T., Meaburn, K. J., Figgitt, M., Kill, I. R., Eskiw, C. H., & Bridger, J. M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.640200 · Cited by 12
“, 2019) through the Secretory Associated Senescence Pathway (SASP), inducing senescence in nearby cells (Acosta et al., 2013), termed paracrine senescence (Hernandez-Segura et al.”
BackgroundThe Regulatory Role of MicroRNAs on Phagocytes: A Potential Therapeutic Target for Chronic Diseases
Wang, Y., Liu, X., Xia, P., Li, Z., FuChen, X., Shen, Y., Yu, P., & Zhang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.901166 · Cited by 11
“When in an infection or inflammatory response, macrophages first exhibit the M1 phenotype to resist the stimulation to release anti-inflammatory factors such as TNF-a and IL-1b.”
BackgroundInfluentialPalmieri, L., Malvezzi, H., de Azevedo, B. C., & Podgaec, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-21431-w · Cited by 11
Alhaddad, L., Nofal, Z., Pustovalova, M. V., Osipov, A. N., & Leonov, S. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032002 · Cited by 10
“Later on, it was shown that the senescence phenotype can be transmitted in a paracrine manner from fibroblasts undergoing oncogeneinduced senescence to normal human fibroblasts and that the transmitted phenotype is stable [34].”
BackgroundCellular population dynamics shape the route to human pluripotency
Panariello, F., Gagliano, O., Luni, C., Grimaldi, A., Angiolillo, S., Qin, W., Manfredi, A., Annunziata, P., Slovin, S., Vaccaro, L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37270-w · Cited by 11
Habiballa, L., Hruby, A. J., Granic, A., Dodds, R. M., Hillman, S. J., Jurk, D., Passos, J. F., & Sayer, A. A. (2023) · GeroScience · doi:10.1007/s11357-023-00869-4 · Cited by 11
“…are characterised by irreversible cell-cycle arrest and the secretion of a range of pro-inflammatory cytokines, chemokines, growth factors, and extracellular matrix degrading proteins termed the senescence-associated secretory phenotype (SASP) [17, 18] that contribute to tissue dysfunction [19].”
Tumor-infiltrating myeloid cells drive senescence evasion and chemoresistance in tumors
Mitri, D. D., Toso, A., & Alimonti, A. (2015) · OncoImmunology · doi:10.4161/2162402x.2014.988473 · Cited by 9
“Indeed, IL-1ra has been previously reported to impair oncogene-induced senescence in vitro by blocking IL-1a mediated signaling.(10) Interestingly, Pten null mice adoptively transferred with IL-1ra-null bone marrow precursors, displayed an almost complete normalization of glands affected by prostatic intraepithelial n…”
BackgroundEffects of childhood exposure to PM2.5 in a Memphis pediatric asthma cohort
Oyana, T. J., Podila, P. S. B., & Relyea, G. E. (2019) · Environmental Monitoring and Assessment · doi:10.1007/s10661-019-7419-y · Cited by 9
Immune Response: A Missed Opportunity Between Vitamin D and Radiotherapy
Yu, X., Liu, B., Zhang, N., Wang, Q., & Cheng, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.646981 · Cited by 13
“SASP can influence the neighboring non-irradiated cells by releasing a series of proinflammatory chemokines and cytokines such as IL-1β, IL-6, and CXCL1 into the surrounding environment (Acosta et al., 2013).”
BackgroundSarkar, A., & Nazir, A. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02640-2 · Cited by 10
Suzuki, Y., Takaya, K., Watanabe, S., Otaki, M., Kono, H., & Kishi, K. (2022) · Aging · doi:10.18632/aging.203966 · Cited by 9
Sun, X., Yu, J., Wang, Y., Luo, J., Zhang, G., & Peng, X. (2022) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.12010 · Cited by 9
“35 Some studies have found that SASP secretion increases in in fl ammation or tumor, 36 which is consistent with our speculation.”
Karen‐Ng, L. P., Ahmad, U. S., Gomes, L., Hunter, K. D., Wan, H., Hagi‐Pavli, E., & Parkinson, E. K. (2022) · Cancers · doi:10.3390/cancers14112636 · Cited by 8
“The cytokine network is orchestrated in both 83 normal and OIS by interleukin-1 alpha [24] and is responsible for the clearance of 84 pre-malignant cells in vivo in concert with the innate and adaptive immune systems [25].”
BackgroundEllis, P. S., Martins, R. R., Thompson, E. J., Farhat, A., Renshaw, S. A., & Henriques, C. M. (2022) · Immunity & Ageing · doi:10.1186/s12979-022-00287-8 · Cited by 10
“Additionally, senescent-like macrophages have also been shown to induce senescence in other cells in a paracrine fashion, known as the “bystander effect”, thereby capable of amplifying the accumulation of senescent cells in vivo [106, 107].”
BackgroundIntercellular communication and aging
Ribeiro‐Rodrigues, T., Kelly, G., Korolchuk, V. I., & Girão, H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823761-8.00005-7 · Cited by 14
Could senescence phenotypes strike the balance to promote tumor dormancy?
Chiu, F.-Y., Kvadas, R. M., Mheidly, Z., Shahbandi, A., & Jackson, J. G. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10089-z · Cited by 8
“Indeed, SASP factors are known to mediate angiogenesis [43, 101, 102] through the production of VEGF, FGF, interleukins, chemokines, matrix metalloproteinases (MMPs), and proteins associated with chromatin remodeling [92, 103].”
BackgroundRejuvenation of Senescent Mesenchymal Stem Cells to Prevent Age-Related Changes in Synovial Joints
Sekelova, T., Danišovič, Ľ., & Čeháková, M. (2023) · Cell Transplantation · doi:10.1177/09636897231200065 · Cited by 11
“The findings of Acosta et al. 65 confirmed that some secreted factors, such as IL-1, can be involved in both autocrine and paracrine senescence.”
BackgroundThe Senescence Arrest Program and the Cell Cycle
Bitto, A., Crowe, E. P., Lerner, C. A., Torres, C. A., & Sell, C. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0888-2_8 · Cited by 9
Talemi, S. R., Kollárovič, G., Lapytsko, A., & Schaber, J. (2015) · Scientific Reports · doi:10.1038/srep13540 · Cited by 10
Gaur, M., Wang, L., Amaro-Ortiz, A., Dobke, M. K., Jordan, I. K., & Lunyak, V. V. (2017) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000396 · Cited by 12
“These data demonstrate significant differences in the composition of SASP from the different models of cellular senescence.”
BackgroundResultInfluentialDopaminergic mediation in the brain aging and neurodegenerative diseases: a role of senescent cells
Nekrasov, P. V., & Vorobyov, V. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.230290 · Cited by 9
“SASP expression has been shown to be under control of an inflammatory signal IL-1 and, evoking local tissue inflammation and ROS rise in normal cells, to be able to induce both the aging of these cells and their transformation into SC (Passos et al., 2010; Acosta et al., 2013).”
BackgroundAn Overview of the Molecular and Cellular Biomarkers of Aging
Solovev, I. A., Shaposhnikov, M. V., & Moskalev, A. (2019) · Healthy ageing and longevity · doi:10.1007/978-3-030-24970-0_6 · Cited by 11
Cellular senescence in neurodegenerative diseases
Zhang, P., & Sung, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00012-2 · Cited by 10
A Proteomic Atlas of Senescence-Associated Secretomes for Aging Biomarker DevelopmentPreprint
Basisty, N., Kale, A., Jeon, O. H., Kuehnemann, C., Payne, T., Rao, C., Holtz, A. N., Shah, S., Ferrucci, L., Campisi, J., et al. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3380253 · Cited by 18
Neretti, N., Evans, S. A., Teo, Y. V., Hinthorn, S. J., Clark, K., Ito, T., & Sedivy, J. M. (2023) · doi:10.59368/agingbio.20230008 · Cited by 16
“SASP leads to inflammation disrupting the tissue microenvironment, reinforces the senescent phenotype by contributing to the cell cycle arrest, and can induce paracrine senescence in normal cells 8,9 .”
Wilkinson, A. L., Hulme, S., Kennedy, J. I., Mann, E. R., Horn, P., Shepherd, E. L., Yin, K., Zaki, M. Y. W., Hardisty, G. R., Lu, W., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107966 · Cited by 11
Effect of miR-21 in mesenchymal stem cells-derived extracellular vesicles behavior
Morente-López, M., Mato-Basalo, R., Lucio-Gallego, S., Gil, C., Carrera, M., Fafián‐Labora, J., Mateos, J., & Arufe, M. C. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03613-z · Cited by 15
Kalisperati, P., Spanou, E., Pateras, I. S., Evangelou, K., Thymara, I., Korkolopoulou, P. A., Kotsinas, A., Vlachoyiannopoulos, P. G., Tzioufas, A. G., Kanellopoulos, C., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073888 · Cited by 10
Chen, W., Chen, X., Yao, L., Feng, J., Li, F., Shan, Y., Ren, L., Zhuo, C., Feng, M., Zhong, S., et al. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.06.020 · Cited by 7
“This is consistent with previous reports that SASPs enhance and spread senescence in an autocrine and paracrine manner, and activates immune responses that eliminate senescent cells [40,41].”
A defective splicing machinery promotes senescence through MDM4 alternative splicing
Deschênes, M., Durand, M., Olivier, M., Pellerin‐Viger, A., Rodier, F., & Chabot, B. (2024) · Aging Cell · doi:10.1111/acel.14301 · Cited by 11
“The SASP also promotes paracrine senescence in neighboring cancerous cells, adding another layer of defense against cancer progression (Acosta et al., 2013; Faget et al., 2019; Langhi Prata et al., 2023).”
Zhao, C., Rong, K., Liu, P., Kong, K., Li, H., Zhang, P., Chen, X., Fu, Q., & Wang, X. (2024) · Communications Biology · doi:10.1038/s42003-024-06664-x · Cited by 10
Wu, Q., Zhang, S., & Cao, R. (2024) · BMC Oral Health · doi:10.1186/s12903-024-05048-1 · Cited by 12
“The SASP further promotes cellular senescence in nearby cells, exacerbating the inflammatory response [37, 38].”
Background
Metadata
- Authors
- Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., Pascual, G., Morris, K. J., Khan, S., Jin, H., Dharmalingam, G., Snijders, A. P., Carroll, T., Capper, D., Pritchard, C., Inman, G. J., Longerich, T., Sansom, O. J., Benitah, S. A., Zender, L., & Gil, J.
- Affiliations
- Imperial College London (GB)
- Centre for Genomic Regulation (ES)
- Cancer Research UK Scotland Institute (GB)
- University of Tübingen (DE)
- German Cancer Research Center (DE)
- University of Leicester (GB)
- University of Dundee (GB)
- Corresponding author
- Gil, Jesús
- ORCID
- Acosta, Juan Carlos
- Banito, Ana
- Janich, Peggy
- Morton, Jennifer P.
- Athineos, Dimitris
- Lasitschka, Felix
- Andrulis, Mindaugas
- Pascual, Gloria
- Khan, Sadaf
- Jin, Hong
- Snijders, Ambrosius P.
- Carroll, Thomas
- Capper, David
- Pritchard, Catrin
- Inman, Gareth J.
- Longerich, Thomas
- Sansom, Owen J.
- Benitah, Salvador Aznar
- Zender, Lars
- Gil, Jesús
- Venue
- Nature Cell Biology
- Published
- 2013-06-16
- Volume
- 15
- Issue
- 8
- Pages
- 978-990
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC3732483
- OpenAlex
- W2140930678
- Semantic Scholar
- 59786bed7ce43f9317328cd82838f14d911e5dd4
- Cited by
- 2,278
- References
- 54
- Citations by year
- 2026: 247 · 2025: 225 · 2024: 232 · 2023: 240 · 2022: 264 · 2021: 250 · 2020: 202 · 2019: 154 · 2018: 119 · 2017: 107 · 2016: 89 · 2015: 79 · 2014: 56 · 2013: 13
- FWCI
- 54.88
- Type
- journal article
- Language
- en
- Update notices
- correction (2026-04-28)
- Open access
- green
- europepmc.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- NERC Open Research Archive (Natural Environment Research Council) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (acceptedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Cancer Research UK (A7769, 13083, 11650, 12481)
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- oncogene-induced senescence, senescence-associated secretory phenotype, paracrine senescence, inflammasome, IL-1 signaling, TGF-beta ligands, vascular endothelial growth factor, MCP-1, CCL20, CDKN2B, p21, tumor suppression, senescence-associated secretome
- MeSH terms
- Animals, Colonic Neoplasms, Humans, Immunohistochemistry, Interleukin-1, Protein Binding, Signal Transduction, Gene Expression Regulation, Neoplastic, Cellular Senescence, Paracrine Communication, Models, Animal, Cell Line, Tumor, Mice, Transforming Growth Factor beta1, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.